Senvest Management LLC Sells 28,387 Shares of Axcelis Technologies, Inc. (NASDAQ:ACLS)

Senvest Management LLC lowered its stake in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS - Free Report) by 3.6% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 770,490 shares of the semiconductor company's stock after selling 28,387 shares during the quarter. Axcelis Technologies makes up approximately 2.8% of Senvest Management LLC's holdings, making the stock its 14th largest position. Senvest Management LLC owned approximately 2.36% of Axcelis Technologies worth $80,786,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of ACLS. Signaturefd LLC raised its stake in Axcelis Technologies by 348.9% during the 2nd quarter. Signaturefd LLC now owns 211 shares of the semiconductor company's stock valued at $30,000 after purchasing an additional 164 shares during the period. Blue Trust Inc. raised its stake in Axcelis Technologies by 223.8% during the 2nd quarter. Blue Trust Inc. now owns 272 shares of the semiconductor company's stock valued at $39,000 after purchasing an additional 188 shares during the last quarter. Ashton Thomas Private Wealth LLC acquired a new stake in shares of Axcelis Technologies during the 2nd quarter worth approximately $39,000. Isthmus Partners LLC raised its position in Axcelis Technologies by 87.3% in the second quarter. Isthmus Partners LLC now owns 33,270 shares of the semiconductor company's stock worth $47,000 after purchasing an additional 15,507 shares in the last quarter. Finally, Meeder Asset Management Inc. bought a new position in Axcelis Technologies during the second quarter worth about $69,000. 89.98% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

ACLS has been the subject of a number of research analyst reports. Needham & Company LLC reiterated a "hold" rating on shares of Axcelis Technologies in a research note on Friday, November 8th. Benchmark lowered Axcelis Technologies from a "buy" rating to a "hold" rating in a research report on Friday, November 8th. Finally, B. Riley reduced their target price on shares of Axcelis Technologies from $190.00 to $165.00 and set a "buy" rating on the stock in a research note on Friday, August 2nd. Three equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. According to data from MarketBeat, Axcelis Technologies has a consensus rating of "Moderate Buy" and an average target price of $167.33.

Axcelis Technologies Stock Up 2.4 %

ACLS traded up $1.79 during trading on Friday, hitting $75.07. The company had a trading volume of 546,839 shares, compared to its average volume of 755,805. The firm's 50-day moving average price is $91.99 and its 200 day moving average price is $111.20. Axcelis Technologies, Inc. has a one year low of $69.35 and a one year high of $158.61. The company has a market capitalization of $2.44 billion, a PE ratio of 11.11, a PEG ratio of 2.28 and a beta of 1.60. The company has a quick ratio of 3.29, a current ratio of 4.45 and a debt-to-equity ratio of 0.04.

About Axcelis Technologies

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.